Novel uncompetitive N-methyl-D-aspartate (NMDA)-receptor antagonist MRZ 2/579 suppresses ethanol intake in longterm ethanol-experienced rats and generalizes to ethanol cue in drug discrimination procedure

Journal of Pharmacology and Experimental Therapeutics

Volumn 292, Issue 2, 2000, Pages 545-552

  Hölter, Sabine M ^a   Danysz, Wojciech ^a,b   Spanagel, Rainer ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b MERZ PHARMACEUTICALS GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NERAMEXANE; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DISCRIMINATION; DRUG EFFECT; DRUG SCREENING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALCOHOL DRINKING; ANIMALS; CYCLOPENTANES; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SELF ADMINISTRATION; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 0043234820     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Burish TG, Maisto SA, Cooper AM and Sobell MB (1981) Effects of voluntary short-term abstinence from alcohol on subsequent drinking patterns of college students. J Stud Alcohol 42:1013-1020.
2. Colombo G and Grant KA (1992) NMDA receptor complex antagonists have ethanol-like discriminative stimulus effects. Ann NY Acad Sci 654:421-423.
3. Danysz W, Parsons CG, Karcz-Kubicha M, Wedzony K, Gold M, Hölter SM, Kalvinsh I, Kauss V and Jirgensons A (1997) Behavioural characterisation of amino-alkyl-cyclohexane derivatives - novel uncompetitive NMDA receptor antagonists. Soc Neurosci Abstr 23:921.
4. Darstein M, Albrecht C, López-Francos L, Knörle RL, Hölter SM, Spanagel R and Feuerstein TJ (1998) Release and accumulation of neurotransmitters in the rat brain: Acute effects of ethanot in vitro and effects of long-term voluntary ethanol intake. Alcohol Clin Exp Res 22:704-709.
5. Faingold CL, N'gouemo PN and Riaz A (1998) Ethanol and neurotransmitter interactions - from molecular to integrative effects. Prog Neurobiol 55:509-535.
6. Hesselink MB, Parsons CG, Wollenburg C and Danysz W (1999) Brain distribution of an uncompetitive NMDA receptor antagonist: Comparison to its in vitro potency in electrophysiological studies. Naunyn-Schmiedeberg's Arch Pharmacol 360:144-150.
7. Heyser CJ, Schulteis G, Durbin P and Koob GF (1998) Chronic acamprosate treatment eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Neuropsychopharmacology 18:125-133.
8. Hölter SM, Danysz W and Spanagel R (1996) Evidence for alcohol anti-craving properties of memantine. Eur J Pharmacol 314:R1-R2.
9. Hölter SM, Engelmann M, Kirschke C, Liebsch G, Landgraf R and Spanagel R (1998) Long-term ethanol self-administration with repeated ethanol deprivation episodes changes ethanol drinking pattern and increases anxiety-related behaviour during ethanol deprivation in rats. Behav Pharmacol 9:41-48.
10. Hölter SM, Landgraf R, Zieglgänsberger W and Spanagel R (1997) Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation. Alcohol Clin Exp Res 21:862-868.
11. Hölter SM and Spanagel R (1999) Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats. Psychopharmacology 145:360-369.
12. Hundt W, Danysz W, Hölter SM and Spanagel R (1998) Ethanol and N-methyl-D-aspartate receptor complex interactions: A detailed drug discrimination study in the rat. Psychopharmacology 135:44-51.
13. Kornet M, Goosen C and Van Ree JM (1991) Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys. Psychopharmacology 104: 367-376.
14. Krystal JH, Petrakis IL, Webb E, Cooney NL, Karper LP, Namanworth S, Stetson P, Trevisan LA and Charney DS (1998) Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. Arch Gen Psychiatry 55:354-360.
15. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE and Rounsaville B (1992) Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Arch Gen Psychiatry 49:881-887.
16. Parsons CG, Danysz W, Bartmann A, Spielmanns P, Frankiewicz T, Hesselink M, Eilbacher B and Quack G (1999) Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: In vitro and in vivo characterization. Neuropharmacology 38:85-108.
17. Parsons CG, Danysz W and Quack G (1998) Glutamate in CNS disorders as a target for drug development: An update. Drug News Perspect 11:523-569.
18. Parsons CG, Quack G, Bresink I, Baran L, Przegalinski E, Kostowski W, Krzascik P, Hartmann S and Danysz W (1995) Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo. Neuropharmacology 34:1239-1258.
19. Piasecki J, Koros E, Dyr W, Kostowski W, Danysz W and Bienkowski P (1998) Ethanol-reinforced behaviour in the rat - effects of uncompetitive NMDA receptor antagonist, memantine. Eur J Pharmacol 354:135-143.
20. Popik P, Mamczarz J, Fraczek M, Widla M, Hesselink M and Danysz W (1998) Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists. Neuropharmacology 37:1033-1042.
21. Rassnick S, Pulvirenti L and Koob GF (1992) Oral ethanol self-administration in rats is reduced by the administration of dopamine and glutatmate receptor antagonists into the nucleus accumbens. Psychopharmacology 109:92-98.
22. Rudolph JG, Walker DW, Iimuro Y, Thurman RG and Crews FT (1997) NMDA receptor binding in adult rat brain after several chronic ethanol treatment protocols. Alcohol Clin Exp Res 21:1508-1519.
23. Sass H, Soyka M, Mann K and Zieglgänsberger W (1996) Relapse prevention by acamprosate: Results from a placebo controlled study in alcohol dependence. Arch Gen Psychiatry 53:673-680.
24. Shelton KL and Balster RL (1994) Ethanol drug discrimination in rats: Substitution with GABA agonists and NMDA antagonists. Behav Pharmacol 5:441-450.
25. Shelton KL and Balster RL (1997) Effects of gamma-aminobutyric acid agonists and N-methyl-D-asparatate antagonists on a multiple schedule of ethanol and saccharin self-administration in rats. J Pharmacol Exp Ther 280:1250-1260.
26. Sinclair JD (1971) The alcohol-deprivation effect in monkeys. Psychonom Sci 25:21-22.
27. Sinclair JD and Senter RJ (1967) Increased preference for ethanol in rats following alcohol deprivation. Phychonom Sci 8:11-12.
28. Spanagel R and Hölter SM (1999) Long-term alcohol self-administration with repeated alcohol deprivation phases: An animal model of alcoholism? Alcohol Alcohol 34:231-243.
29. Spanagel R, Hölter SM, Allingham K, Landgraf R and Zieglgänsberger W (1996) Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat. Eur J Pharmacol 305:39-44.
30. Spanagel R and Zieglgänsberger W (1997) Anti-craving compounds for ethanol: New pharmacological tools to study addictive processes. Trends Pharmacol Sci 18:55-59.
31. Spencer DGJ and Emmett-Oglesby MW (1985) Parallel processing strategies in the application of microcomputers to behavioral laboratories. Behav Res Methods Instrum 17:294-297.
32. Tabakoff B and Hoffman PL (1996) Alcohol addiction: An enigma among us. Neuron 16:909-912.
33. Tsai G and Coyle JT (1998) The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Ann Rev Med 49:173-184.
34. Tsai G, Gastfriend DR and Coyle JT (1995) The glutamatergic basis of human alcoholism. Am J Psychiatry 152:332-340.
35. Volpicelli JR, Alterman AI, Hayashida M and O'Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876-880.
36. B sites. Eur J Pharmacol 347:183-187.
37. Whitworth AB, Fischer F, Lesch OM, Nimmerrichter A, Oberbauer H, Platz T, Potgieter A, Walter H and Fleischhacker WW (1996) Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet 347:1438-1442.
38. Wolffgramm J and Heyne A (1991) Social behavior, dominance, and social deprivation of rats determine drug choice. Pharmacol Biochem Behav 38:389-399.